Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien J B, Kamara L, Landry S
Immunization Vaccines and Biologicals Department (IVB), Expanded Programme on Immunization (EPI), World Health Organization (WHO), 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.
Vaccine. 2008 Dec 2;26(51):6706-16. doi: 10.1016/j.vaccine.2008.10.015.
This paper reviews the experience of the Global Alliance for Vaccines and Immunization (GAVI) in introducing hepatitis B and Haemophilus influenzae type b vaccines in the poorest countries, and explores how financing for immunization has changed since GAVI Fund resources were made available during its first wave of support between 2000 and 2006. The analysis of Financial Sustainability Plans in 50 countries allowed for some of the original funding assumptions of the GAVI approach to be tested against the realities in a wide set of countries, and to highlight implications for future immunization efforts. While the initial GAVI experience with financial sustainability has proved successful through the development of plans, and many countries have been able to both introduce new vaccines and mobilize additional financing for immunization, for future GAVI supported vaccine introduction, some country co-financing of these will be needed upfront for the approach to be more sustainable.
本文回顾了全球疫苗免疫联盟（GAVI）在最贫困国家引入乙肝疫苗和b型流感嗜血杆菌疫苗的经验，并探讨了自2000年至2006年GAVI基金在其第一轮支持期间提供资金以来，免疫融资情况发生了怎样的变化。对50个国家的财务可持续性计划进行分析，使得GAVI方法的一些原始资金假设能够在众多国家的现实情况中得到检验，并突出对未来免疫工作的影响。虽然通过制定计划，GAVI在财务可持续性方面的初步经验已证明是成功的，而且许多国家既能够引入新疫苗，又能够为免疫工作筹集额外资金，但对于未来由GAVI支持的疫苗引入，需要一些国家预先共同出资，以使该方法更具可持续性。
